Deprenyl and the issue of neuroprotection.
Vingerhoets
F J
FJ
Uitti
R J
RJ
Calne
D B
DB
D000975:Antioxidants / Q000008:administration & dosage*; D002470:Cell Survival / Q000187:drug effects; D002986:Clinical Trials as Topic; D004185:Disability Evaluation; D004334:Drug Administration Schedule; D006801:Humans; D007980:Levodopa / Q000008:administration & dosage; D009474:Neurons / Q000187:drug effects; D010300:Parkinson Disease / Q000188:drug therapy* / Q000209:etiology; D012642:Selegiline / Q000008:administration & dosage*; D013378:Substantia Nigra / Q000187:drug effects; D014810:Vitamin E / Q000008:administration & dosage
D000975:Antioxidants; D014810:Vitamin E; D012642:Selegiline; D007980:Levodopa